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ARTICLE INFO ABSTRACT
Article Type:
Orignal Article Introduction: The aim of this randomized controlled trial was to compare the radiographic
and clinical success rates of direct pulp capping (DPC) using ProRoot mineral trioxide
aggregate (MTA) or calcium enriched mixture (CEM). Methods and Materials: A total of 42
symptom-free carious vital primary molars (21 pairs) were selected in this split mouth trial
and randomly pulpotomized in two experimental groups. Pinpoint pulp exposures were
covered by the same blinded operator with MTA or CEM, and then restored by amalgam.
Radiographic and clinical successes were evaluated at 20 month follow-up. Data were
statistically analyzed using McNemar test. Results: Nineteen patients were available for 20-
month follow-up; only one failed tooth was extracted in the CEM group. All available teeth
were symptom-free, however, the final evaluated success rate was 89% in CEM (CI 95%: 0.82-
0.96) and 95% in MTA (CI 95%: 0.85-1) groups without statistical difference (P=0.360).
Worst case scenario was applied for missing value analysis; assuming that the 2 lost cases in
CEM group had failed and the only lost case in MTA group was due to treatment success, as
a result the success of CEM and MTA were 81% (CI 95%: 0.72-0.90) and 95% (CI 95%:0.85-
1), respectively, with no statistical difference (P=0.078). In the reverse scenario, the success of
MTA and CEM were 86% (CI 95%: 0.78-0.94) and 90% (CI 95%: 0.82-0.98), respectively;
again with no statistical difference (P=0.479). Conclusion: Effectiveness of MTA and CEM
biomaterials for primary molars’ DPC was similar; CEM can be a suitable alternative for MTA.
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irect pulp capping (DPC) is more common for
human permanent teeth rather than deciduous ones
[1]. While DPC on immature permanent teeth is a
universally accepted treatment protocol, DPC in primary
teeth is currently controversial. Reports of favorable pulp
response in primary molars after DPC of traumatic or
mechanical exposure are rather infrequent; however, positive
outcomes for DPC of carious pulp exposure that it is
surrounded by normal dentine have been reported [2, 3].
Numerous materials have been suggested for DPC
including calcium hydroxide (CH), zinc oxide eugenol
(ZOE), formocresol (FC), polycarboxylate, adhesive resins,
enamel matrix derivate (EMD), beta-tricalcium phosphate,
NaOCl and mineral trioxide aggregate (MTA) [1, 4-7]. As the
traditional pulp capping agent, CH showed worse clinical
and histological outcomes in comparison with some other
tested materials [7-9]; however, a recent clinical trial revealed
that DPC with CH or MTA has similar results [10].
MTA is originated from Portland cement and has shown
superior sealability and biocompatibility but less cytotoxicity
than other pulp covering materials [11]. There are more than
1000 research articles regarding this rather new biomaterial
in PubMed [12] which revealed that MTA stimulates the
healing of dental pulp and periodontium [13, 14]. Despite
being suggested as a suitable alternative for formocresol (FC)
in primary premolars pulpotomy [15], it is rather expensive
and has a long setting time with potential tooth discoloration
[16]. Providentially, introduction of new biomaterials has
caused a change in the old idea that DPC of a carious pulp
exposure in a primary tooth is not recommended [17-20].
Calcium enriched mixture (CEM) cement demonstrated
biocompatibility in both ex vivo and in vivo studies [21-26]; it
D
Fallahinejad et al.150
IEJ Iranian Endodontic Journal 2013;8(4):149-152
has antimicrobial activity, appropriate sealing ability, and
quickly sets in aqueous environment [27-29]. Recent
randomized clinical trials revealed that CEM pulpotomy in
primary molars was equally successful to MTA after 2-year
[30, 31]. A recent case report, as the best histological and
cone beam computed tomography (CBCT) evidence, showed
that CEM can induce a thick and complete calcific bridge
with tubular dentin after pulpotomy of a primary molar [32].
We previously reported that DPC of primary molars with
MTA or CEM cement at 6-month had similar success rates
[33]. The aim of this part of the clinical trial was to assess the
long-term treatment outcomes after a 20-month follow up.
Methods and Materials
This split mouth randomized clinical trial was approved by
Ethics Committee of Research Institute of Dental Sciences,
Shahid Beheshti University of Medical Sciences, Tehran, Iran
and was in compliance with the ethical principles of The
Helsinki Declaration.
Same as previously reported materials and methods [33];
twenty one healthy children (5-8 years-old) with at least two
carious second primary molars were included based on
symptom-free vital pulp exposure, presence of at least two-
thirds of the root length, being restorable with amalgam,
availability for 20 months follow-up and parents’ acceptance
with the informed consent. Exclusion criteria were presence
of spontaneous pain, tenderness to percussion, sinus tract,
internal/external root resorption, apical/furcation lesion,
periodontal pocket >3 mm, pathologic luxation, and absence
of successor permanent tooth.
The molars were randomly assigned to experimental
groups. The single operator and also the patients were blind
to biomaterial/treatment. Each tooth was anesthetized and
after isolation, carious lesion was completely removed.
Exposed dental pulp was irrigated with normal saline and
after achieving the hemostasis it was randomly allocated to
be covered either with ProRoot MTA (Dentsply, Tulsa, OK,
USA) or CEM (BioniquDent, Tehran, Iran). The teeth were
restored by amalgam. Any co-interventions was avoided.
Treatment outcomes based on previously reported
criteria [33] were evaluated at 20 months by a calibrated
dentist, radiologist and a statistician who were also blind to
the type of used biomaterial. Data analysis was performed
using the SPSS software, version 16.0 using McNemar test.
The Missing Value analysis as well as intention to treat
analysis was also performed.
Results
Two patients (n=4 teeth; ~10% dropout) missed for long-
term follow-up, due to family migration. Nineteen available
patients were evaluated at 20-months. One tooth in CEM
group was extracted due to failure and as a result 18 teeth in
CEM and 19 teeth in MTA group were available for final
assessment. One more teeth in either group also failed; so the
per protocol success in CEM and MTA groups were 89% (CI
95%: 0.82-0.96) and 95% (CI 95%: 0.85-1), respectively,
without any statistical difference (P=0.360). In addition,
intention to treat analysis showed that there was no
significant difference between two groups (P=0.417).
Missing Value analysis for two opposite worst case
scenarios demonstrated that if the two lost cases in CEM
group are assumed as failure and the only lost case in MTA
group is classified as success, the success rates of CEM and
MTA calculated would be 81% (CI 95%: 0.72-0.90) and 95%
(CI 95%:0.85-1), respectively, with no difference (P=0.078).
In opposite scenario the success of MTA and CEM were 86%
and 90% (CI 95%: 0.78-0.94 and 0.82-0.98, respectively);
again with no statistical difference (P=0.479). Therefore, in
the two worst case scenarios, the obtained results were
comparable and missing data did not affect the outcomes.
Discussion
This split mouth randomized clinical trial in primary molars
with two MTA and CEM endodontic biomaterials is unique
as the study protocol was quadruple-blind and the patients’
variability was minimized by employing a split-mouth
model. DPC was performed blindly at care-provider/patient
level even when the biomaterial was capped; as the
appearance of the two pulp capping biomaterials was tooth-
colored, the single operator did not know what biomaterial
was placed. A blinded pedodontist evaluated the clinical
symptoms and radiographic assessments were carried out by
a blinded oral radiologist. The statistical analyzing of the data
was also carried out blindly. So a well-designed quadruple-
blinded randomized clinical trial without researcher’s
cognitive bias was carried out. Obtained results revealed that
favorable clinical/radiographic treatment outcomes of MTA
and CEM cement for primary molars’ DPC were comparable.
Currently, in the common school of thought, DPC for
primary teeth is not generally recommended as the previous
reported prognosis was not satisfactory [34]; and it is
hypothesized that the high cellular content of primary pulp
tissue may be responsible for failures via differentiation of
mesenchymal cells to odontoclasts that can lead to internal
resorption [35]. Our obtained results, however, did not show
such cases of failure due to internal resorption. Moreover,
our previous report for 6-month follow-up [33] as well as 2-
year results of Tuna and Olmez [10] have confirmed the
present results and simultaneously reject the hypothesis. It
can be hypothesized that under the circumstances of the
underlying pulp, inflammatory mediators can trigger
differentiation of the mesenchymal cells to odontoclasts
which are responsible for dentin resorbtion and thus by
shifting the status from inflammatory to reparative,
CEM/MTA can overcome this issue.
In recent decade, several well-designed randomized
clinical trials as the best current evidence, have assessed the
treatment outcomes of MTA versus FC pulpotomy of
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primary molars; a few systematic reviews in this regard [15,
36, 37] summarized the published evidence and indicated
that MTA is superior to FC in primary molars pulpotomy
resulting in a lower failure rate. In addition, it was reported
that MTA induces a less undesirable response. Therefore the
new school of thought considered MTA as the gold standard
in primary teeth pulp therapy and we employed this
biomaterial for DPC of primary molars as control. Our
favorable obtained results for MTA were in accordance with
previously reported evidence.
CEM cement has been introduced as a new endodontic
biomaterial with different chemical composition from MTA
and this trial intended to study the treatment outcomes of
DPC with this new biomaterial. Evidence-based success in
various vital pulp therapies in human subjects using CEM
cement has been documented [28, 38]; recent randomized
clinical trials have demonstrated successful treatment
outcomes following DPC and pulpotomy of primary molar
teeth using CEM cement [30]. Numerous studies have also
confirmed that CEM cement as an endodontic sealant is
nontoxic [22, 39, 40], biocompatible [41] and promotes
dentinogenesis, cementogenesis and osteogenesis when it is
in contact with the dental pulp, periradicular tissues or bone,
respectively [14, 27, 32, 42]. A recent histological and CBCT
evaluation of a human primary molar pulpotomy using CEM
demonstrated thick/complete tubular dentin bridge
formation [32]. The high success rate of DPC with CEM in
the present report is remarkable, particularly considering the
20-month follow-up period which is concurring with
previous favorable results.
Dropout rate or missing data can negatively influence the
reported effectiveness of randomized clinical trials. In the
present report, in addition to intention to treat analysis, we
present an alternative missing value analyses using worst case
scenario in order to adjust the results for missing values. The
analyses revealed that the effectiveness DPC with CEM is so
strong that even imputing the worst case scenario did not
change the positive results; in other words, missing response
rate is so low that it did not modify the results.
Conclusion
The newer biomaterial, CEM, demonstrated favorable
clinical and radiographic successes as a DPC agent in
primary molars; it seems to be a suitable alternative for high-
price MTA.
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